Vertex Pharmaceuticals

NASDAQ: VRTX · Real-Time Price · USD
391.72
1.42 (0.36%)
At close: Aug 15, 2025, 3:42 PM

Vertex Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
4.97B 4.67B 4.57B 5.24B 4.58B 9.16B 10.37B 11.11B 10.15B 9.29B 10.5B 9.17B 8.7B 7.6B 6.79B 6.28B 6.06B 6.3B
Short-Term Investments
1.41B 1.53B 1.55B 1.29B 1.22B 1.01B 849.2M 818M 1.09B 1.12B 274.5M 599.2M 551.2M 638M 729.9M 685.19M 644.32M 619.64M
Long-Term Investments
5.65B 5.16B 5.11B 4.7B 4.39B 4.38B 2.5B 1.7B 1.36B 1.08B 112.2M n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
1.08B 1.01B 999.3M 990.2M 915.6M 875.7M 895.3M 475.2M 442.7M 427.5M 409.6M 132.5M 127.3M 110.7M 110.8M 75.52M 71.1M 49.26M
Receivables
1.89B 1.81B 1.61B 1.75B 1.66B 1.79B 1.56B 1.54B 1.56B 1.55B 1.44B 1.39B 1.33B 1.29B 1.14B 1.1B 929.14M 977.55M
Inventory
1.5B 1.36B 1.21B 1.08B 914.6M 813.1M 738.8M 688.7M 603.5M 535.1M 460.6M 388.2M 367.7M 338.9M 353.1M 333.46M 321.62M 298.86M
Other Current Assets
652.3M 642.8M 206.5M 449.2M 575.4M 511.1M 86.1M 540.2M 476.9M 468.7M 121.9M n/a n/a n/a 103.7M n/a n/a n/a
Total Current Assets
10.43B 10.01B 9.6B 9.8B 8.94B 13.29B 14.14B 14.7B 13.87B 12.97B 13.23B 12.27B 11.5B 10.36B 9.56B 8.85B 8.46B 8.54B
Property-Plant & Equipment
2.65B 2.63B 2.58B 2.51B 1.77B 1.49B 1.45B 1.43B 1.45B 1.45B 1.46B 1.46B 1.42B 1.44B 1.42B 1.35B 1.34B 1.31B
Goodwill & Intangibles
1.52B 1.53B 1.91B 1.92B 1.93B 1.92B 1.93B 1.69B 1.69B 1.69B 1.69B 1.68B 1.39B 1.4B 1.4B 1.4B 1.4B 1.4B
Total Long-Term Assets
13.61B 12.87B 12.94B 12.44B 11.19B 10.63B 8.59B 7.03B 6.48B 6.01B 4.92B 4.44B 4.08B 3.89B 3.87B 3.77B 3.76B 3.58B
Total Assets
24.04B 22.88B 22.53B 22.24B 20.13B 23.92B 22.73B 21.73B 20.35B 18.97B 18.15B 16.71B 15.58B 14.26B 13.43B 12.62B 12.22B 12.12B
Account Payables
3.71B 445M 413M 395.8M 327.9M 351.4M 364.9M 375.9M 363M 323.2M 303.9M 126.9M 198M 173.6M 195M 127.86M 127.53M 127.84M
Deferred Revenue
n/a n/a 206.8M n/a n/a n/a 170.3M n/a n/a n/a 159.6M n/a n/a n/a 171.7M n/a n/a n/a
Short-Term Debt
n/a n/a 92.3M n/a n/a n/a 83.7M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Liabilities
-3.29B 386.4M -60.9M 357.6M 279.3M 648.6M 189.5M 316.2M 391M 377M 62.5M 218M 238.7M 286.1M 16.5M 201.41M 226.36M 284.17M
Total Current Liabilities
4.14B 3.78B 3.56B 3.97B 3.55B 3.8B 3.55B 3.6B 3.35B 3.03B 2.74B 2.61B 2.56B 2.18B 2.14B 1.91B 1.84B 1.94B
Long-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
1.2B 951.9M 901.8M 933.3M 876.8M 853.6M 877.7M 869.3M 759.3M 726.5M 685.8M 242.9M 245.2M 296.4M 303.3M 296.97M 294.99M 291.96M
Total Long-Term Liabilities
2.72B 2.6B 2.56B 2.64B 1.81B 1.57B 1.6B 1.61B 1.53B 1.52B 1.5B 1.07B 1.09B 1.17B 1.19B 1.17B 1.19B 1.19B
Total Liabilities
6.86B 6.38B 6.12B 6.61B 5.36B 5.37B 5.15B 5.21B 4.88B 4.54B 4.24B 3.68B 3.65B 3.35B 3.33B 3.09B 3.03B 3.13B
Total Debt
1.53B 1.65B 1.75B 1.7B 933.4M 721.3M 808.4M 744.7M 767.6M 789.2M 899.7M 824.6M 847.3M 872.5M 967.4M 876.8M 893.85M 898.8M
Common Stock
256.3M 2.6M 2.6M 2.6M 2.6M 2.6M 2.6M 2.6M 2.6M 2.6M 2.6M 2.6M 2.6M 2.6M 2.5M 2.56M 2.59M 2.59M
Retained Earnings
16.92B 10.25B 9.61B 8.69B 7.65B 11.24B 10.14B 9.17B 8.14B 7.22B 6.52B 5.7B 4.77B 3.96B 3.2B 2.43B 1.58B 1.51B
Comprehensive Income
-101.1M 68.1M 127.8M 28.8M 22.5M 17.3M -14.3M -3M -39.8M -13.1M 800K 97.6M 57.5M 11.3M 15.9M 11.54M -25.16M -33.3M
Shareholders Equity
17.18B 16.5B 16.41B 15.63B 14.77B 18.55B 17.58B 16.51B 15.47B 14.43B 13.91B 13.03B 11.93B 10.91B 10.1B 9.53B 9.2B 8.98B
Total Investments
5.65B 6.68B 6.65B 5.99B 5.61B 5.39B 3.35B 2.52B 2.44B 2.21B 386.7M 599.2M 551.2M 638M 729.9M 685.19M 644.32M 619.64M